Cnbx Pharmaceuticals Inc.

CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma

CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate

CNBX Pharmaceuticals Announces New Patent Granted in Australia